2024-25 Guide to Medications for the Treatment of Diabetes Mellitus

The 2024-25 Guide to Medications for the Treatment of Diabetes Mellitus is a complete and newly revised reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide addresses all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Each discussion reflects the latest guidance of the American Diabetes Association's Standards of Care in Diabetes. This guide also features chapters on medication management of comorbidities such as:
- Neuropathy
- Chronic Kidney Disease
- Retinopathy
- Hypoglycemia
- Obesity
- Depression

Author: John R. White
Publisher: American Diabetes Association
Published: 07/09/2024
Pages: 644
Binding Type: Paperback
Weight: 1.75lbs
Size: 8.90h x 5.90w x 1.50d
ISBN13: 9781580408387
ISBN10: 1580408389
BISAC Categories:
- Medical | Drug Guides
- Health & Fitness | Diseases & Conditions | Diabetes
- Medical | Clinical Medicine

About the Author
JOSHUA J. NUEMILLER, PHARMD, CDCES, FADCES, FASCP, is Vice Chair and Allen I. White Distinguished Professor, Pharmacotherapy, at the College of Pharmacy and Pharmaceutical Sciences at Washington State University. Dr. Neumiller currently serves as the ADA's president-elect for healthcare & education and is the author of Practical Insulin.